Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
ISIS-PKKRx
.
Show all posts
Showing posts with label
ISIS-PKKRx
.
Show all posts
Friday, May 30, 2014
Isis Pharmaceuticals starts Phase 1 clinical study of ISIS-PKKRx to treat patients with HAE
›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it initiated a Phase 1 clinical study of ISIS-PKK Rx . ISIS-PKK Rx is an antis...
›
Home
View web version
